Although cOPN may not be a specific marker for SLE, it may be a more upstream event compared with biomarkers of flare such as NGAL; therefore, it may have value as a marker for cumulative disease progression resulting in organ damage. The gene discussed is LCN2; the disease is systemic lupus erythematosus.